Financial Performance - For Q1 2023, total revenues increased by 670millionto2,921 million, compared to 2,251millioninQ12022,drivenbycontributionsfromdealersoftwareandnucleartechnologyservicesoperations[142].−Directoperatingcostsroseby526 million to 2,551millioninQ12023,upfrom2,025 million in Q1 2022, primarily due to acquisitions in dealer software and nuclear technology services [143]. - General and administrative expenses increased by 39millionto107 million in Q1 2023, compared to 68millioninQ12022,mainlyduetorecentacquisitions[144].−NetlossforQ12023was185 million, an increase of 22millionfromanetlossof163 million in Q1 2022 [141]. - Interest expense, net increased by 172millionto279 million in Q1 2023, compared to 107millioninQ12022,attributedtohigherborrowingsandinterestrates[145].−RevenuesforQ12023were2,921 million, a decrease of 6.5% from Q4 2022's 3,124million[150].−NetincomeforQ12023wasalossof185 million, compared to a profit of 158millioninQ42022[150].−AdjustedEBITDAforQ12023was622 million, an increase from 486millioninQ12022[164].CashFlowandLiquidity−CashflowusedinoperatingactivitiesforthethreemonthsendedMarch31,2023was140 million, compared to cash provided of 34millionforthesameperiodin2022[175].−Cashflowprovidedbyfinancingactivitieswas89 million for the three months ended March 31, 2023, a significant improvement from cash used of 155millioninthesameperiodin2022[176].−Cashflowprovidedbyinvestingactivitieswas110 million for the three months ended March 31, 2023, compared to cash used of 135millioninthesameperiodin2022[177].−Thecompanyaimstomaintainsufficientliquiditythroughcashflows,creditfacilities,andmonetizationofmatureoperations[165].−AsofMarch31,2023,thecompanyhadcashandcashequivalentsof810 million, an increase from 736millionasofDecember31,2022[173].AssetsandLiabilities−Accountsreceivableincreasedby321 million to 3,512millionasofMarch31,2023,duetotimingofbilledreceivables[155].−Otherassetsroseby343 million to 1,809millionasofMarch31,2023,attributedtoreclassificationofanon−coredivision[156].−Goodwilldecreasedby286 million to 6,628millionasofMarch31,2023,primarilyduetoreclassificationrelatedtoanon−coredivision[159].−Non−recourseborrowingsinsubsidiariesincreasedby283 million to 13,196millionasofMarch31,2023,drivenbyhigherborrowingsinwaterandwastewateroperations[165].−Thecompanyhastotalcontractualobligationsof24.65 billion as of March 31, 2023, including borrowings of 13.55billionandpensionobligationsof3.81 billion [184]. Investments and Capital Expenditures - Capital expenditures for Q1 2023 included 47millionformaintenanceand96 million for growth, compared to 42millionand97 million respectively in Q1 2022 [158]. - The company has an equity commitment of 2billionfromBrookfieldBusinessPartnerstoenhanceaccesstoequitycapital[167].−Brookfieldhassubscribedforupto1.5 billion of 6% perpetual preferred equity securities, with 1,475millionsubscribedfromothersubsidiariesasofMarch31,2023[170].OtherFinancialActivities−Theboarddeclaredaquarterlydividendof0.0625 per exchangeable share, payable on June 30, 2023 [172]. - The company has outstanding bank guarantees, insurance bonds, and letters of credit totaling approximately 1.6billionasofMarch31,2023[178].−ThecompanydidnotrepurchaseanyofitsexchangeablesharesduringthethreemonthsendedMarch31,2023[182].−RemeasurementlossesonexchangeableandclassBshareswere121 million in Q1 2023, compared to a loss of 168millioninQ12022,reflectingtheclosingpriceofoneLPUnitat18.62 [146]. - Other net expenses increased by 14millionto57 million in Q1 2023, compared to 43millioninQ12022,including31 million in business separation expenses and restructuring charges [147]. Future Outlook - The company anticipates continued growth in revenues from healthcare services due to higher admission rates and patient days, despite foreign exchange impacts [142]. - The increase in revenues was partially offset by lower revenues from construction operations, indicating a mixed performance across segments [142]. - The company is focused on enhancing cash flows and pursuing new acquisitions to drive future growth [138].